• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过非病毒白细胞介素-2基因转移,人细胞因子诱导的杀伤细胞在体外具有增强的细胞溶解活性。

Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer.

作者信息

Nagaraj Srinivas, Ziske Carsten, Schmidt-Wolf Ingo Gh

机构信息

Department of Internal Medicine I, General Internal Medicine Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany.

出版信息

Genet Vaccines Ther. 2004 Aug 25;2:12. doi: 10.1186/1479-0556-2-12. eCollection 2004.

DOI:10.1186/1479-0556-2-12
PMID:15329148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC516021/
Abstract

Modulation of the immune system by genetically modified immunological effector cells is of potential therapeutic value in the treatment of malignancies. Interleukin-2 (IL-2) is a crucial cytokine which induces potent antitumor response. Cytokine-induced killer cells (CIK) have been described as highly efficient cytotoxic effector cells capable of lysing tumor cell targets and are capable of recognizing these cells in a non-MHC restricted fashion. Dendritic cells (DC) are the major antigen presenting cells. This study evaluated the antitumor effect of CIK cells which were non-virally transfected with IL-2 and co-cultured with pulsed and unpulsed DC. Human CIK cells generated from peripheral blood were transfected with plasmid encoding for the human IL-2. Transfection involved a combination of electrical parameters and a specific solution to deliver plasmid directly to the cell nucleus by using the Nucleofector electroporation system. Nucleofection resulted in the production of IL-2 with a mean of 478.5 pg/10 cells (range of 107.6-1079.3 pg /10 cells/24 h) compared to mock transfected CIK cells (31 pg/10 cells) ( = 0.05). After co-culturing with DC their functional ability was assessed by a cytotoxicity assay. On comparison with non-transfected CIK cells co-cultured with DCs (36.5 ± 5.3 %), transfected CIK cells co-cultured with DC had a significantly higher lytic activity of 58.5 ± 3.2% ( = 0.03) against Dan G cells, a human pancreatic carcinoma cell line.

摘要

通过基因改造的免疫效应细胞调节免疫系统在恶性肿瘤治疗中具有潜在的治疗价值。白细胞介素-2(IL-2)是一种关键的细胞因子,可诱导有效的抗肿瘤反应。细胞因子诱导的杀伤细胞(CIK)已被描述为高效的细胞毒性效应细胞,能够裂解肿瘤细胞靶标,并且能够以非主要组织相容性复合体(MHC)限制的方式识别这些细胞。树突状细胞(DC)是主要的抗原呈递细胞。本研究评估了用IL-2进行非病毒转染并与脉冲和未脉冲的DC共培养的CIK细胞的抗肿瘤作用。从外周血中产生的人CIK细胞用编码人IL-2的质粒转染。转染涉及电参数和特定溶液的组合,以通过使用Nucleofector电穿孔系统将质粒直接递送至细胞核。与mock转染的CIK细胞(31 pg/10个细胞)相比,核转染导致IL-2的产生,平均为478.5 pg/10个细胞(范围为107.6 - 1079.3 pg /10个细胞/24小时)(P = 0.05)。与DC共培养后,通过细胞毒性试验评估它们的功能能力。与与DC共培养的未转染CIK细胞(36.5±5.3%)相比,与DC共培养的转染CIK细胞对人胰腺癌细胞系Dan G细胞具有明显更高的裂解活性,为58.5±3.2%(P = 0.03)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/516021/ef299ba82a2d/1479-0556-2-12-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/516021/ef299ba82a2d/1479-0556-2-12-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/516021/ef299ba82a2d/1479-0556-2-12-1.jpg

相似文献

1
Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer.通过非病毒白细胞介素-2基因转移,人细胞因子诱导的杀伤细胞在体外具有增强的细胞溶解活性。
Genet Vaccines Ther. 2004 Aug 25;2:12. doi: 10.1186/1479-0556-2-12. eCollection 2004.
2
[Killing activity of co-cultured cytokine-induced killer cells and dendritic cells against multi-drug resistant tumor cell lines].[共培养的细胞因子诱导杀伤细胞和树突状细胞对多药耐药肿瘤细胞系的杀伤活性]
Zhonghua Zhong Liu Za Zhi. 2007 Oct;29(10):733-7.
3
Enhanced cytotoxicity of IL-24 gene-modified dendritic cells co-cultured with cytokine-induced killer cells to hepatocellular carcinoma cells.白细胞介素 24 基因修饰的树突状细胞与细胞因子诱导的杀伤细胞共培养增强对肝癌细胞的细胞毒性。
Int J Hematol. 2010 Sep;92(2):276-82. doi: 10.1007/s12185-010-0654-1. Epub 2010 Aug 11.
4
Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations.树突状细胞与细胞因子诱导的杀伤细胞之间的相互作用导致这两种细胞群体均被激活。
J Immunother. 2001 Nov-Dec;24(6):502-10. doi: 10.1097/00002371-200111000-00007.
5
Inducible costimulator (ICOS) enhances the cytolytic activity of cytokine-induced killer cells against gallbladder cancer in vitro and in vivo.诱导性共刺激分子(ICOS)在体外和体内均可增强细胞因子诱导的杀伤细胞对胆囊癌的细胞溶解活性。
Cancer Invest. 2009 Mar;27(3):244-50. doi: 10.1080/07357900802239124.
6
Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene.通过白细胞介素-7基因的受体介导转染提高扩增的人CD3 + CD56 +免疫效应细胞的增殖率并增强其抗肿瘤细胞毒性。
Gene Ther. 1998 Jan;5(1):31-9. doi: 10.1038/sj.gt.3300560.
7
Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.白细胞介素-2基因转染的自体免疫效应细胞应用于转移性肾癌、结直肠癌和淋巴瘤患者的I期临床研究。
Br J Cancer. 1999 Nov;81(6):1009-16. doi: 10.1038/sj.bjc.6690800.
8
[Effect of Achyranthes bidentata polysaccharides stimulated dendritic cells co-cultured with cytokine induced killer cells against SW480 cells].牛膝多糖刺激树突状细胞与细胞因子诱导的杀伤细胞共培养对SW480细胞的作用
Zhongguo Zhong Yao Za Zhi. 2013 Apr;38(7):1056-60.
9
[Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo].共培养树突状细胞和细胞因子诱导的杀伤细胞对肺癌的体内外抗肿瘤作用
Ai Zheng. 2006 Nov;25(11):1329-33.
10
Influence of dendritic cells on biological activity of the homologous CIK cells and its anti-leukemia effect in vitro.树突状细胞对同源CIK细胞生物学活性的影响及其体外抗白血病作用
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):946-51.

引用本文的文献

1
PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer.PD-L1 表达是乳腺癌术后患者基于 CIK 细胞的免疫治疗的预测性生物标志物。
J Immunother Cancer. 2019 Aug 27;7(1):228. doi: 10.1186/s40425-019-0696-8.
2
Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy.嵌合抗原受体 T 细胞靶向 EGFRvIII 治疗转移性肺癌。
Front Med. 2019 Feb;13(1):57-68. doi: 10.1007/s11684-019-0683-y. Epub 2019 Feb 5.
3
Co-culture of dendritic cells and cytokine-induced killer cells effectively suppresses liver cancer stem cell growth by inhibiting pathways in the immune system.

本文引用的文献

1
Cytokine requirements for the growth and development of mouse NK cells in vitro.体外培养小鼠自然杀伤细胞生长和发育所需的细胞因子
J Leukoc Biol. 2003 Aug;74(2):233-42. doi: 10.1189/jlb.0303097.
2
What to do with targeted IL-2.如何处理靶向白细胞介素-2。
Drugs Today (Barc). 2000 May;36(5):321-36. doi: 10.1358/dot.2000.36.5.575044.
3
Analysis of in vitro immunization: generation of cytotoxic T-lymphocytes against allogeneic melanoma cells with tumor lysate-loaded or tumor RNA-transfected antigen-presenting cells.体外免疫分析:用负载肿瘤裂解物或转染肿瘤RNA的抗原呈递细胞产生针对同种异体黑色素瘤细胞的细胞毒性T淋巴细胞。
树突状细胞和细胞因子诱导的杀伤细胞共培养通过抑制免疫系统中的途径有效抑制肝癌干细胞生长。
BMC Cancer. 2018 Oct 16;18(1):984. doi: 10.1186/s12885-018-4871-y.
4
Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer.细胞因子诱导的杀伤细胞作为一种可行的过继免疫疗法用于治疗肺癌。
Cell Death Dis. 2018 Mar 6;9(3):366. doi: 10.1038/s41419-018-0404-5.
5
Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature review.基于自体细胞因子诱导的杀伤细胞免疫疗法治疗子宫内膜癌的临床疗效:病例报告及文献综述
Onco Targets Ther. 2017 Sep 22;10:4687-4690. doi: 10.2147/OTT.S147714. eCollection 2017.
6
Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways.抗CD20抗体通过STAT和MAPK/ERK信号通路诱导细胞因子诱导的杀伤细胞活性增强。
Exp Ther Med. 2015 Apr;9(4):1215-1222. doi: 10.3892/etm.2015.2264. Epub 2015 Feb 5.
7
Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients.癌症患者中树突状细胞疫苗联合细胞因子诱导的杀伤细胞疗法的免疫反应、临床结果及安全性
Oncol Lett. 2013 Aug;6(2):537-541. doi: 10.3892/ol.2013.1376. Epub 2013 Jun 4.
8
Cellular immunotherapy for carcinoma using genetically modified EGFR-specific T lymphocytes.用基因修饰的 EGFR 特异性 T 淋巴细胞进行癌的细胞免疫治疗。
Neoplasia. 2013 May;15(5):544-53. doi: 10.1593/neo.13168.
9
Cytokine-induced NK-like T cells: from bench to bedside.细胞因子诱导的自然杀伤样T细胞:从 bench 到 bedside。 (注:bench 可理解为实验室研究阶段,bedside 可理解为临床应用阶段,这里直接保留英文是因为在医学领域有时保留特定英文表述更准确传达含义且符合习惯)
J Biomed Biotechnol. 2010;2010:435745. doi: 10.1155/2010/435745. Epub 2010 Mar 30.
10
Cytokine-induced killer cells are type II natural killer T cells.细胞因子诱导的杀伤细胞是II型自然杀伤T细胞。
Ger Med Sci. 2007 Sep 10;5:Doc07.
Cancer Immunol Immunother. 2003 Mar;52(3):171-8. doi: 10.1007/s00262-002-0339-6. Epub 2003 Feb 11.
4
Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cells.与树突状细胞共培养后产生具有细胞毒性活性的活化且抗原特异性的T细胞。
Cancer Immunol Immunother. 2002 Mar;51(1):25-32. doi: 10.1007/s00262-001-0251-5. Epub 2001 Dec 21.
5
Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations.树突状细胞与细胞因子诱导的杀伤细胞之间的相互作用导致这两种细胞群体均被激活。
J Immunother. 2001 Nov-Dec;24(6):502-10. doi: 10.1097/00002371-200111000-00007.
6
[Exosomes derived from dendritic cells].[源自树突状细胞的外泌体]
J Soc Biol. 2001;195(1):25-7.
7
Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.通过瘤内注射携带人白细胞介素-2 cDNA 的腺病毒载体对小鼠已建立的肿瘤进行免疫治疗:诱导 CD8(+) T 细胞免疫和自然杀伤细胞活性。
Cancer Gene Ther. 2001 May;8(5):321-32. doi: 10.1038/sj.cgt.7700309.
8
Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs.用CIITA基因转染树突状细胞(DCs):DCs免疫刺激活性增强。
Cancer Gene Ther. 2001 Mar;8(3):211-9. doi: 10.1038/sj.cgt.7700292.
9
Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.采用质粒编码细胞因子联合体内电穿孔进行有效的肿瘤治疗。
Cancer Res. 2001 Apr 15;61(8):3281-4.
10
Immunotherapy of renal cell carcinoma by intratumoral administration of an IL-2 cDNA/DMRIE/DOPE lipid complex.通过瘤内注射白细胞介素-2 cDNA/DMRIE/DOPE脂质复合物对肾细胞癌进行免疫治疗。
Curr Opin Mol Ther. 2001 Feb;3(1):70-6.